- Informatics Resources – Center for Drug Repurposing🔍
- The NIH's Drug Repurposing Program Gets Going🔍
- An OpenData portal to share COVID|19 drug repurposing data in ...🔍
- Funding available to repurpose existing drugs🔍
- "Triune Synergy in Biomedical Research🔍
- VUMC aids national effort to repurpose drugs for COVID|19🔍
- Peer Review History🔍
- NCATS OpenData COVID|19🔍
NCATS Drug Repurposing
Informatics Resources – Center for Drug Repurposing
NCATS Inxight: Drugs –. The National Center for Advancing Translational Sciences (NCATS) has developed Inxight: Drugs as a comprehensive ...
The NIH's Drug Repurposing Program Gets Going | Science | AAAS
Here's an update on the NIH's NCATS program to repurpose failed clinical candidates from the drug industry. I wrote about this effort here ...
An OpenData portal to share COVID-19 drug repurposing data in ...
The National Center for Advancing Translational Sciences (NCATS) has developed an online open science data portal for its COVID-19 drug repurposing campaign – ...
Funding available to repurpose existing drugs - ITHS
The National Center for Advancing Translational Science (NCATS) has announced two funding opportunities for researchers to test existing drugs and biologics ...
"Triune Synergy in Biomedical Research: Uniting Pharmaceutical ...
Triune Synergy in Biomedical Research: Uniting Pharmaceutical Companies, University Researchers, and the NIH through the Drug Repurposing Project at NCATS ...
VUMC aids national effort to repurpose drugs for COVID-19
Enrollment is expected to open by this summer to participants who are at least 30 years old, have tested positive for infection by SARS-CoV-2, ...
PONE-D-23-21475Exploring NCATS In-House Biomedical Data for Evidence-based Drug RepurposingPLOS ONE. Dear Dr. Zhu,. Thank you for submitting your manuscript ...
NCATS OpenData COVID-19 - NIST COVID19 Registry
The aim is to enable a variety of drug repurposing activities and allow researchers to formulate and test hypotheses, prioritize research opportunities and ...
NIH's NCATS Establishes $20M Collaborative Drug Repositioning ...
NIH's new National Center for Advancing Translational Sciences (NCATS) has launched an initiative through which pharma companies' sidelined drug ...
3 Enabling Tools and Technology | Drug Repurposing and ...
REPURPOSING AT NCATS. The Therapeutics for Rare and Neglected Diseases (TRND) program is a collaborative drug discovery and development research program, not ...
>400,000 compounds, 15 yrs. ~3500 drugs. 1-2 years? Page 8. Enabling Comprehensive Drug Repurposing. Page 9. Workflow for the NPC library.
CURE ID App Lets Clinicians Report Novel Uses of Existing Drugs
Repurposing approved drugs for new clinical uses can potentially offer an efficient drug ... NCATS called the CURE Drug Repurposing Collaboratory ...
Multimedia | National Center for Advancing Translational Sciences
NCATS Drug Repurposing. Drug repurposing finds approved drugs and investigational compounds that might be able to treat other diseases and conditions. We use ...
CURE-ID - National Center for Advancing Translational Sciences
... National Institutes of Health (NIH) to capture these treatment experiences. ... drug repurposing or off-label use). By collecting these cases directly from ...
FDA Backs New Effort to Repurpose Drugs As COVID-19 Treatments
FDA is teaming up with the Critical Path Institute and National Center for Advancing Translational Sciences (NCATS) to launch the CURE Drug ...
Drug Repurposing: A Leading Strategy for New Threats and Targets
... (NCATS) are doing good work. Still, university researchers need ... Therapeutic drug repurposing, repositioning and rescue: Part II: Business ...
Repurposing Challenges: Conceptualization of a Research Agenda
... repurposing projects to date has led to a new drug or indication approval. Complementing this rational, or opportunistic, approach is the NCATS Pharmaceutical ...
Drug Discovery and Repurposing Core (DDRC)
... NCATS, which connects them to the CTSA consortium. This network will provide unique resources for rapidly translating existing drugs for new clinical trials.
How drug repurposing can advance drug discovery: challenges and ...
National consortia · Institutional partnerships · Collaborators. More from ... Drug repurposing (DR), often referred to as drug repositioning, is a drug ...
Adapted from Lo, FDA & NCATS workshop in "Repurposing Off-Patent Drugs: Research and Regulatory Challenges, 2019. Page 23. • EU- and Canada-approved drug ...